YAU YI CHING 4
4 · BridgeBio Pharma, Inc. · Filed Jun 5, 2020
Insider Transaction Report
Form 4
YAU YI CHING
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-06-03+45,931→ 45,931 totalExercise: $28.86Exp: 2030-06-02→ Common Stock (45,931 underlying) - Award
Restricted Stock Units
2020-06-03+6,383→ 6,383 total→ Common Stock (6,383 underlying)
Footnotes (3)
- [F1]The Option will vest over approximately four years. 1/48th of the shares of Common Stock underlying the Option will vest on a monthly basis after June 3, 2020 (the "Vesting Commencement Date"), such that all of the shares underlying the Option will be vested on the date four (4) years after the Vesting Commencement Date, subject to the Reporting Person's continued Service Relationship (as defined in the Plan) with the Issuer or any of its subsidiaries through the applicable vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.